Missouri’s governor signed into law SB 579 (the “Act”), on June 8, 2016, establishing new telemedicine practice standards, including explicitly allowing a valid physician-patient relationship to be established via telemedicine. Here is a summary of the Act’s key provisions:
- Telemedicine. “Telehealth” and “telemedicine” is defined as the delivery of health care services by means of information and communication technologies which facilitate the assessment, diagnosis, consultation, treatment, education, care management, and self-management of a patient’s health care while such patient is at the originating site and the health care provider is at the distant site. Telemedicine also includes asynchronous store-and-forward technology.
- Onsite Clinicians. There is no requirement for any patient-site telepresenter, unless necessary to meet the standard of care for the treatment of the patient’s medical condition.
- Licensure. Providers must be licensed to practice in Missouri, unless they meet a licensure exception (e.g., consultation).
- Consultations. The Act adds the following consultation exceptions:
- An informal consultation performed by a health care provider licensed in another state, outside of the context of a contractual relationship, and on an irregular or infrequent basis without the expectation or exchange of direct or indirect compensation;
- Furnishing of health care services by a health care provider licensed and located in another state in case of an emergency or disaster; provided that, no charge is made for the medical assistance; or
- Episodic consultation by a health care provider licensed and located in another state who provides such consultation services on request to a physician in Missouri.
- Physician-Patient Relationship and Standard of Care. A valid physician-patient relationship must be established with the person receiving the telemedicine services, and this can be done via telemedicine if the standard of care does not require an in-person encounter. The telemedicine technology must be sufficient to allow an informed diagnosis as though the medical interview and physical examination was performed in person. Prior to providing treatment or issuing prescriptions, the physician must interview the patient, collect and review relevant medical history, and perform an examination sufficient for the diagnosis and treatment of the patient. A questionnaire, whether via the internet or telephone, is not an acceptable medical interview and examination for the provision of treatment by telehealth. A physician-patient relationship established via telemedicine must include the following elements:
- Obtaining a reliable medical history and performing a physical examination of the patient adequate to establish the diagnosis for which the drug is being prescribed and to identify underlying conditions or contradictions to the treatment recommended or provided;
- Having sufficient dialogue with the patient regarding treatment options and the risks and benefits of treatment or treatments;
- If appropriate, following up with the patient to assess the therapeutic outcome;
- Maintaining a contemporaneous medical record that is readily available to the patient and, subject to the patient’s consent, to the patient’s other health care professionals, and
- Maintaining the electronic prescription information as part of the patient’s medical record.
- Remote Prescribing. Physicians may prescribe drugs via telemedicine, including controlled substances, only in connection with a valid physician-patient relationship and the requirements set forth above.
- Telephone Evaluations and Internet Questionnaires. No health care provider may prescribe any drug, controlled substance, or other treatment to a patient based solely on a telephone evaluation unless a previously-established and ongoing physician-patient relationship exists between such physician and the patient. No health care provider may prescribe any drug, controlled substance, or other treatment based solely on an internet request or an internet questionnaire.
- Disclosures and Informed Consent. The Act does not explicitly require disclosures or informed consent to the patient prior to providing telemedicine services.
Originally, this post was an alert sent to the American Health Lawyers Association’s (AHLA) Health and Information Technology Practice Group Members. It appears here with permission. For more information, visit AHLA’s website.
Disclaimer
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
Author(s)
Related Insights
26 July 2024
Foley In Fashion
Passing the Torch: Technology in the Opening Ceremony Fashion at the Paris Olympics
With the 2024 Olympic Games set in Paris, France, one of the world’s fashion capitals, athletics and aesthetics collide to take center stage at the much-anticipated opening ceremony.
25 July 2024
Foley In Fashion
SHEIN’s $1.9 Million Data Breach: A Cautionary Tale for Online Fashion Brands
The New York Attorney General fined fast-fashion company, Shein Distribution Corporation, $1.9 million for failing to properly handle a data breach in late 2022.
25 July 2024
Manufacturing Industry Advisor
Unlocking the Power of Equity-Based Incentive Compensation: Basics of Nonqualified Stock Options and Stock-Settled Stock Appreciation Rights for Employers in the Manufacturing Industry
This article is the second in our series on equity-based compensation intended to assist employers with answering a common question: What type of equity compensation award is best for our company and our employees?